Aaki GmbH & Co. KG
- Address
- Reumannplatz 17, Favoriten, 1100 Vienna, Austria
Aaki GmbH & Co. KG - Allergy Research Center
Aaki GmbH & Co. KG is a specialized research facility dedicated to advancing therapeutic interventions for allergic conditions. The center demonstrates particular expertise in investigating allergen-specific immunotherapy and novel treatments for respiratory allergic diseases, with a strong focus on seasonal allergic manifestations.
- Seasonal allergic rhinitis and rhinoconjunctivitis
- Birch pollen-induced allergic responses
- Sublingual immunotherapy efficacy and safety studies
The research center conducts rigorous randomized controlled trials evaluating innovative immunotherapy formulations for patients suffering from pollen-induced allergies. Their clinical investigations emphasize both efficacy and safety outcomes, contributing valuable evidence to the field of allergy and immunology therapeutics.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 152 other sites in Austria
Therapeutic Area Benchmark — Austria
Select a therapeutic area to compare against other sites in Austria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Austria
Market Share
Country: Austria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Aaki GmbH & Co. KG
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of PQ Birch in Patients with Birch Pollen-Induced Seasonal Allergic Rhinitis and Rhinoconjunctivitis | Allergy Therapeutics (UK) Limited | Phase III | Not Yet Recruiting | — | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Placebo | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.